The healthcare sector has frequently been the target of antitrust enforcement against large providers and insurers, as well as merger transactions. What should healthcare organizations keep in mind when entering into transactions or other collaborations? Are there special rules applying to healthcare organizations with significant positions in healthcare markets? This seminar, presented by Lisl Dunlop from Axinn Veltrop, will address the key antitrust issues that arise in the healthcare industry and lessons to be drawn from recent enforcement actions.
Lisl Dunlop has more than twenty-five years of experience in antitrust and competition issues, including counseling, litigation, and transactions. Lisl guides clients through the antitrust-related aspects of mergers and acquisitions, joint ventures and other combinations, and sales and distribution matters. She also represents clients in antitrust agency investigations, and has represented major corporations in complex antitrust litigations.
Lisl has significant experience advising leading U.S. and multinational companies in a broad range of industries, including the media, technology, and healthcare sectors. For her healthcare clients, Lisl provides antitrust and strategic advice in evaluating value-based payment initiatives, the establishment and operation of ACOs and independent physician networks, financial and clinical integration issues, and other transactions and collaborations.
Presenter engagingly and knowledgeably highlighted key antitrust issues that arise in the healthcare industry and shared lessons to be drawn from recent enforcement actions.
Interesting topic, enjoyed how inclusive healthcare was.
Knowledgeable and easy delivery